Arch Dis Child Fetal Neonatal Ed 79:F110-F113 doi:10.1136/fn.79.2.F110
  • Original article

Randomised controlled trial of cisapride in feed intolerance in preterm infants

  1. Alma Enriquez,
  2. Srinivas Bolisetty,
  3. Sanjay Patole,
  4. Paul A Garvey,
  5. Peter J Campbell
  1. Department of Newborn Care, Royal Hospital for Women, Randwick New South Wales 2031, Australia
  1. D. Peter Campbell.
  • Accepted 11 March 1998


AIM To assess the efficacy of cisapride in reducing the time required to establish enteral feeds in preterm infants.

METHODS A randomised, double blind, placebo controlled trial was conducted of 34 infants of ⩽ 32 weeks of gestation, assigned to receive either cisapride 0.2 mg/kg/dose four times daily (n=18) or placebo (n=16).

RESULTS The time taken by the babies to tolerate full enteral feeds was not significantly different between the groups (median 9.5 days vs 10 days). There was a significantly lower incidence of large gastric residuals and regurgitation in the treated group compared with the placebo group. The number of episodes of large gastric residuals per infant was also significantly less. No adverse effects were noted.

CONCLUSION The routine use of cisapride in preterm infants cannot be recommended to decrease the time to establish enteral feeds. Its use may be justified for clincally significant gastric stasis or regurgitation.


    Latest from Education & Practice

    Latest from Education & Practice

    Register for free content

    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Fetal & Neonatal.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    Navigate This Article